Abstract
The US Institute of Medicine and the International Committee of Medical Journal Editors (ICMJE), among others, have called for clinical trialists to declare their plans to share individual participant data (IPD) and related study documents for secondary research prior to study initiation.1-3 Individual participant data, which refers to measurements collected from each research participant, is distinct from aggregated data usually reported in journal articles or in the ClinicalTrials.gov results database.1 The term IPD sharing refers to the practice of making clinical trial data at the individual level available to researchers who were not part of the original study team.4